GLP-Based Therapies
An Educational Guide to Modern Metabolic Medications
In recent years, a new class of medications has reshaped the landscape of weight loss and metabolic health: GLP-based therapies. These treatments work by influencing key hormonal pathways that control appetite, insulin response, energy usage, and fat storage. As research
evolves, so do the options—and understanding how these medications differ can help you make the most informed decisions.
At NeuLogics, we believe education is the foundation of empowerment. Whether you’re just
starting your weight loss journey or exploring what’s next, we’re here to provide the clarity you need.
GLP-Based Therapies
An Educational Guide to Modern Metabolic Medications
In recent years, a new class of medications has reshaped the landscape of weight loss and metabolic health: GLP-based therapies. These treatments work by influencing key hormonal pathways that control appetite, insulin response, energy usage, and fat storage. As research
evolves, so do the options—and understanding how these medications differ can help you make the most informed decisions.
At NeuLogics, we believe education is the foundation of empowerment. Whether you’re just
starting your weight loss journey or exploring what’s next, we’re here to provide the clarity you need.
Mechanisms: How They Work
Works by activating GLP-1 receptors, which slow gastric emptying, suppress appetite, and support blood sugar regulation. It has become a cornerstone in weight loss therapy but may result in greater lean body mass loss if not supported with resistance training or adjunctive therapies.
targets both GLP-1 and GIP receptors, enhancing glucose regulation and promoting deeper satiety. Its dual-action profile may help preserve some lean mass while improving insulin and lipid metrics.
A triple-agonist currently under clinical investigation. By stimulating GIP, GLP-1, and glucagon receptors, it may offer greater fat oxidation and muscle- sparing effects. While still in trials, the mechanism is promising and continues to generate attention in the field of body composition–focused therapeutics.
Comparison of GLP Therapies
Semaglutide
(Brand Names: Wegovy®, Ozempic®)-
Mechanism: GLP-1 receptor agonist
-
FDA Status: Approved
-
Average Weight Loss: ~15%
-
Muscle Mass Impact: May reduce lean mass
-
Injection Frequency: Weekly
-
How It Works: Suppresses appetite and improves blood sugar control
-
Side Effects: GI symptoms like nausea are common
Retatrutide
(Emerging Therapy)-
Mechanism: Triple GIP/GLP-1/Glucagon receptor agonist
-
FDA Status: In late-stage clinical trials
-
Average Weight Loss: ~24%+ (early data)
-
Muscle Mass Impact: Early data suggests best preservation of lean mass
-
Injection Frequency: Weekly
-
How It Works: Suppresses appetite, enhances glucose control, and boosts fat oxidation via glucagon pathway
-
Side Effects: Similar GI symptoms + possible glucagon-related effects (e.g., increased heart rate)
Tirzepatide
(Brand Name: Mounjaro®)-
Mechanism: Dual GIP/GLP-1 receptor agonist
-
FDA Status: Approved
-
Average Weight Loss: ~21%
-
Muscle Mass Impact: Moderate preservation of lean mass (GIP benefit)
-
Injection Frequency: Weekly
-
How It Works: Reduces appetite, improves glucose and lipid profiles
-
Side Effects: GI side effects like nausea, potentially milder than semaglutide
What Should You Consider When Choosing a GLP Path?
Each medication works a bit differently and may suit different types of patients:
- Some individuals do well on semaglutide but may reach a plateau
- Others may benefit from the enhanced metabolic effects of tirzepatide
- And many are curious about the next generation of treatments, like retatrutide, which may reshape how we think about weight loss and long-term health in the future
The right choice depends on your goals, body composition, lifestyle, and medical history—as well as how your body responds over time.
Our Approach at NeuLogics
GLP therapies are just one component of our precision approach to metabolic health. At NeuLogics, we structure every plan to include:
- Comprehensive body composition tracking
- Metabolic and hormonal lab analysis
- Integration of movement, nutrition, and peptide-based strategies
- Ongoing reassessment as your body adapts and evolves
We're not here to treat numbers. We're here to restore function, optimize fat-to-muscle ratio, and support sustained, body-positive transformation.
A Note on
Innovation
As the field evolves, we stay aligned with current data and next-generation tools. Therapies like retatrutide represent a natural progression in metabolic care—offering deeper access to fat-burning pathways and lean mass preservation strategies. If you're curious about whether a single, dual, or triple pathway therapy is right for you, our team will walk you through all the available options.
Want To
Learn More?
If you're exploring GLP therapies for the first time, or wondering whether it's time to progress to
a more advanced protocol, we're here to help. We invite you to schedule a consultation to discuss
your goals, learn which pathway is right for you, and build a plan that evolves with your
progress.
Contact NeuLogics to begin a more precise, more informed metabolic journey.
We've Got Answers
It comes down to how many hormone receptors they target. Semaglutide uses one pathway,
tirzepatide uses two, and retatrutide (in trials) uses three. More targets may mean more
comprehensive metabolic support—but they also come with unique considerations we’ll review
together.
Yes. Many patients benefit from adjusting their therapy based on results, tolerance, or changes in
body composition. Our providers will help determine if a transition makes sense for you.
Plateaus are common and often signal the need to reassess your dosing, metabolic strategy, or
medication pathway. In many cases, transitioning to a dual or multi-pathway therapy may offer
renewed progress—especially when supported with nutritional and hormonal optimization.
Yes. Many patients report a noticeable reduction in food noise, impulsive eating, and carb cravings.
These effects can improve emotional control around food, especially in the early phases of treatment.
If GLPs are stopped without lifestyle or metabolic support, regaining weight is possible. That’s
why our protocols include long-term planning, including muscle preservation, hormonal
balance, and sustainable nutrition strategies to help maintain your results.
